Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 15, 2012 (Vol. 32, No. 20)

Regen Med Nears the Market

  • Two of the main barriers to making regenerative medicine products more widely available are high prices and the difficulty for surgeons and clinicians to implement them in their routine clinical practice, reported Nick Skaer, Ph.D., CEO of Orthox, at Regener8’s recent “Regenerative Therapies” conference in Newcastle, U.K. “Early ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.